Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA advisory panel rejects J&J drug for acute coronary syndrome
FDA advisory panel rejects J&J drug for acute coronary syndrome
FDA advisory panel rejects J&J drug for acute coronary syndrome
Submitted by
admin
on January 16, 2014 - 4:54pm
Source:
Reuters
News Tags:
JNJ
acute coronary syndrome
Xarelto
advisory panels
FDA
Headline:
FDA advisory panel rejects J&J drug for acute coronary syndrome
Do Not Allow Advertisers to Use My Personal information
